BIRC5 and breast carcinoma: For example, cisplatin treatment of prostate cancer cells resulted in upregulation of Survivin, XIAP and cIAP2; adriamycin-resistant MCF7 breast cancer cells showed upregulation of XIAP and Survivin; and Lapatinib-resistant BT474 breast cancer cells had elevated Survivin levels.